Dr David Goldstein

Honorary Associate
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre


Map

Selected grants

2013

  • Improving patient outcomes for patients with Gastrointestinal (GI) cancer through clinical trials research: An application on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG); Goldstein D, Simes R, Abdi E, Ackland S, Pavlakis N, Shannon J; Cancer Institute New South Wales/Cooperative Clinical Trial (CCT) Grants.

2012

  • Personalising care in resectable pancreas cancer. GAP-T: a study of imaging and molecular biomarkers to guide treatment of patients receiving preoperative chemotherapy followed by surgery.; Barbour A, Goldstein D, Goldstein D, Kench J, Yip S, Brown C, Hicks R, Chang D; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • DOCetaxel with or without radiation Therapy for resectable Oesophageal adenocarcinoma based on early PET Response to induction chemotherapy (DOCTOR); Goldstein D, Brown C, Yip S, Barbour A; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Development and operational support for AGITG and ANZGOG through the NHMRC Clinical Trials Centre: A NSW-led initiative; Simes R, Friedlander M, Goldstein D, Gainford M; Cancer Institute New South Wales/Clinical Trials Infrastructure Grants.
  • Biostatistics, quality assurance and data systems for cancer trial groups activities based at the NHMRC Clinical Trials Centre; Gebski V, Simes R, Hague W, Gainford M, Stockler M, Goldstein D, Friedlander M, Grimison P; Cancer Institute New South Wales/Clinical Trials Infrastructure Grants.
  • Phase III Study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy and +/- erlotinib; Goldstein D, Shannon J, Spry N, Padbury R, Shannon J, Biankin A, Kneebone A, FitzGerald P; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2007

  • Phase II study of chemotherapy and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer; Shannon J, Goldstein D, Shannon J, Lipton L, Ackland S, Karapetis C, Van Hazel G; Cancer Council New South Wales/Research Project Grants.
  • Adjuvant chemotherapies in resectable pancreatic cancer; Goldstein D, Padbury R, Shapiro J, Grimes D; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Butow, P., Tattersall, M., Clayton, J., Goldstein, D. (2013). Breaking Bad News and Truth Disclosure in Australia. In Antonella Surbone, Matjaz Zwitter, Mirjana Rajer, Richard Stiefel (Eds.), New Challenges in Communication with Cancer Patients, (pp. 377-387). New York: Springer.

Journals

  • Hillman, R., Garland, S., Gunathilake, M., Stevens, M., Kumaradevan, N., Lemech, C., Ward, R., Meagher, A., McHugh, L., Jin, F., et al (2014). Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. International Journal of Cancer, 135(4), 996-1001. [More Information]
  • Grimison, P., Phillips, F., Butow, P., White, K., Yip, D., Sardelic, F., Underhill, C., Tse, R., Simes, R., Turley, K., et al (2013). Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals. Asia-Pacific Journal of Clinical Oncology, 9(3), 226-238. [More Information]
  • Park, S., Goldstein, D., Krishnan, A., Lin, C., Friedlander, M., Cassidy, J., Koltzenburg, M., Kiernan, M. (2013). Chemotherapy-induced peripheral neurotoxicity: A critical analysis. CA: A Cancer Journal for Clinicians, 63(6), 419-437. [More Information]
  • Chou, A., Waddell, N., Cowley, M., Gill, A., Chang, D., Patch, A., Nones, K., Wu, J., Pinese, M., Johns, A., Toon, C., et al (2013). Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5(8), 1-11. [More Information]
  • Short (nee Rybovic), M., Goldstein, D., Halkett, G., Reece, W., Borg, M., Zissiadis, Y., Kneebone, A., Spry, N. (2013). Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer. International Journal of Radiation: Oncology - Biology - Physics, 85(1), 157-162. [More Information]
  • Butow, P., Aldridge, L., Bell, M., Sze, M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Duggal, P., McGrane, J., et al (2013). Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study. European Journal of Cancer, 49(8), 1948-1956. [More Information]
  • Bell, M., Butow, P., Goldstein, D. (2013). Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors. Quality of Life Research, 22(10), 2757-2760. [More Information]
  • Shaw, J., Butow, P., Sze, M., Young, J., Goldstein, D. (2013). Reducing disparity in outcomes for immigrants with cancer: a qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention. Supportive Care in Cancer, 21(8), 2297-2301. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information]
  • Butow, P., Bell, M., Aldridge, L., Sze, M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Duggal, P., et al (2013). Unmet needs in immigrant cancer survivors: a cross-sectional population-based study. Supportive Care in Cancer, 21(9), 2509-2520. [More Information]
  • Butow, P., Lobb, E., Jefford, M., Goldstein, D., Eisenbruch, M., Girgis, A., King, M., Sze, M., Aldridge, L., Schofield, P. (2012). A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Supportive Care in Cancer, 20(2), 235-244. [More Information]
  • Goldstein, D., Bennett, B., Webber, K., Boyle, F., De Souza, P., Wilcken, N., Scott, E., Toppler, R., Murie, P., O'Malley, L., Hickie, I., et al (2012). Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study. Journal of Clinical Oncology, 30(15), 1805-1812. [More Information]
  • Bennett, B., Park, S., Lin, C., Friedlander, M., Kiernan, M., Goldstein, D. (2012). Impact of oxaliplatin-induced neuropathy: a patient perspective. Supportive Care in Cancer, 20(11), 2959-2967. [More Information]
  • Cameron, B., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A. (2012). Post-cancer fatigue is not associated with immune activation or altered cytokine production. Annals of Oncology, 23(11), 2890-2895. [More Information]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(5), 496-504. [More Information]
  • Butow, P., Phillips, F., Schweder, J., White, K., Underhill, C., Goldstein, D. (2012). Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Supportive Care in Cancer, 20(1), 1-22. [More Information]
  • Ngan, S., Burmeister, B., Fisher, R., Solomon, M., Goldstein, D., Joseph, D., Ackland, S., Schache, D., McClure, B., McLachlan, S., et al (2012). Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. Journal of Clinical Oncology, 30(31), 3827-3833. [More Information]
  • Goldstein, D., Spry, N., Cummins, M., Brown, C., van Hazel, G., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S., Wratten, C., Hruby, G., Horvath, L., Gebski, V., et al (2012). The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British Journal of Cancer, 106(1), 61-69. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Dose effects of oxaliplatin on persistent and transient na conductances and the development of neurotoxicity. PLoS One, 6(4), e18469-e18469. [More Information]
  • Butow, P., Sze, M., Duggal-Beri, P., Mikhail (nee Tanious), M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Goldstein, D. (2011). From inside the bubble: migrants' perceptions of communication with the cancer Team. Supportive Care in Cancer, 19(2), 281-290. [More Information]
  • Butow, P., Bell, M., Goldstein, D., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Ashgari, R., Hui, R., et al (2011). Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters. Patient Education and Counseling, 84, 398-405. [More Information]
  • Webber, K., Mok, K., Bennett, B., Lloyd, A., Friedlander, M., Juraskova, I., Goldstein, D. (2011). If I Am in the Mood, I Enjoy It: An Exploration of Cancer-Related Fatigue and Sexual Functioning in Women with Breast Cancer. The Oncologist, 16, 1333-1344. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility. The Oncologist, 16(5), 708-716. [More Information]
  • Park, S., Goldstein, D., Lin, C., Krishnan, A., Friedlander, M., Kiernan, M. (2011). Neuroprotection for Oxaliplatin-Induced Neurotoxicity: What Happened to Objective Assessment? Journal of Clinical Oncology, 29(18), e553-e554. [More Information]
  • Luckett, T., Goldstein, D., Butow, P., Gebski, V., Aldridge, L., McGrane, J., Ng, W., King, M. (2011). Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. The Lancet Oncology, 12(13), 1240-1248. [More Information]
  • Tebbutt, N., Murphy, F., Zannino, D., Wilson, C., Cummins, M., Abdi, E., Strickland, A., Lowenthal, R., Marx, G., Karapetis, C., Shannon, J., Simes, R., et al (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology, 22(8), 1834-1838. [More Information]
  • Sze, M., Butow, P., Goldstein, D., Jefford, M., Girgis, A., Eisenbruch, M., Bell, M., Vaccaro, L., Dong, S., Liauw, W., et al (2011). Shared Decision Making in Immigrants With Cancer. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 20(Suppl 2), 12-13.
  • Clarke, S., Yip, S., Brown, C., van Hazel, G., Ransom, D., Goldstein, D., Jeffrey, G., Tebbutt, N., Buck, M., Lowenthal, R., Boland, A., Gebski, V., Simes, R., et al (2011). Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis. European Journal of Cancer, 47(12), 1826-1836. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Goldstein, D., Horvath, L., Tattersall, M., et al (2011). Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy. Journal of Clinical Oncology, 29(15), 2077-2084. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Utilising natural activity to dissect the Pathophysiology of acute oxaliplatin-induced neuropathy. Experimental Neurology, 227(1), 120-127. [More Information]
  • Butow, P., Lobb, E., Jefford, M., Goldstein, D., Eisenbruch, M., Girgis, A., King, M., Sze, M., Aldridge, L., Schofield, P. (2010). A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Supportive Care in Cancer, , 1-10. [More Information]
  • Lovell, M., Forder, P., Stockler, M., Butow, P., Briganti, E., Chye, R., Goldstein, D., Boyle, F. (2010). A Randomized Controlled Trial of a Standardized Educational Intervention for Patients with Cancer Pain. Journal of Pain and Symptom Management, 40(1), 49-59. [More Information]
  • Sjoquist, K., Goldstein, D., Bester, L. (2010). A serious complication of selected internal radiation therapy: case report and literature review. The Oncologist, 15(8), 830-835. [More Information]
  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Neoptolemos, J., Stocken, D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M., Gallinger, S., Mariette, C., et al (2010). Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: A Randomized Controlled Trial. JAMA: The Journal of the American Medical Association, 304(10), 1073-1081. [More Information]
  • Goldstein, D., Gainford, M., Brown, C., Tebbutt, N., Ackland, S., van Hazel, G., Jefford, M., Abdi, E., Selva-Nayagam, S., Gebski, V., Miller, D., et al (2010). Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemotherapy and Pharmacology, , 1-7. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Koczwara, B., Francis, K., Marine, F., Goldstein, D., Underhill, C., Olver, I. (2010). Reaching further with online education? The development of an effective online program in palliative oncology. Journal of Cancer Education, 25(3), 317-323. [More Information]
  • Park, S., Goldstein, D., Lin, C., Krishnan, A., Friedlander, M., Kiernan, M. (2009). Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. Journal of Clinical Oncology, 27(8), 1243-1249. [More Information]
  • Girgis, A., Hansen, V., Goldstein, D. (2009). Are Australian oncology health professionals burning out? A view from the trenchs. European Journal of Cancer, 45, 393-399. [More Information]
  • Underhill, C., Bartel, R., Goldstein, D., Snodgrass, H., Begbie, S., Yates, P., White, K., Jong, K., Grogan, P. (2009). Mapping oncology services in regional and rural Australia. Australian Journal of Rural Health, 17, 321-329. [More Information]
  • Chua, W., Goldstein, D., Lee, C., Dhillon, H., Michael, M., Mitchell, P., Clark, S., Iacopetta, B. (2009). Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. British Journal of Cancer, 101(6), 998-1004. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2009). Oxaliplatin-Induced Lhermitte's Phenomenon as a Manifestation of Severe Generalized Neurotoxicity. Neuro-Oncology, 77(6), 342-348. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2009). Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain: a journal of neurology, 132(10), 2712-2723. [More Information]
  • Van Hazel, G., Pavlakis, N., Goldstein, D., Olver, I., Tapner, M., Price, D., Bower, G., Briggs, G., Rossleigh, M., Taylor, D., George, J. (2009). Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy. Journal of Clinical Oncology, 27(25), 4089-4095. [More Information]
  • Lee, C., Hadley, A., DeSilva, K., Smith, G., Goldstein, D. (2009). When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis. World Journal of Surgical Oncology, 7(8), 1-4. [More Information]
  • Butow, P., Girgis, A., Goldstein, D., Eisenbruch, M., Schofield, P., King, M., Jefford, M., Duggal-Beri, P., Sze, M., Mikhail (nee Tanious), M., et al (2008). Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 17, S280-S280.
  • Shepherd, L., Goldstein, D., Olver, I., Parle, M. (2008). Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer? Australian Health Review, 32(3), 423-438. [More Information]
  • Vonlaufen, A., Joshi, S., Qu, C., Phillips, P., Xu, Z., Parker, N., Toi, C., Pirola, R., Wilson, J., Goldstein, D., et al (2008). Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Research, 68(7), 2085-2093. [More Information]
  • Xavier, K., Shepherd, L., Goldstein, D. (2007). Clinical supervision and education via videoconference: a feasibility project. Journal of Telemedicine and Telecare, 13(4), 206-209. [More Information]
  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]
  • Moore, M., Goldstein, D., Hamm, J., Figer, A., Hecht, J., Gallinger, S., Au, H., Murawa, P., Walde, D., Wolff, R., et al (2007). Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 25(15), 1960-1966. [More Information]
  • Clarke, S., Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S. (2007). Modification of Leucovorin Dose Within a Simplified FOLFOX Regimen Improves Tolerability Without Compromising Efficacy. Clinical Colorectal Cancer, 6(8), 578-582. [More Information]
  • Bennett, B., Goldstein, D., Friedlander, M., Hickie, I., Lloyd, A. (2007). The experience of cancer related fatigue and chronic fatigue syndrome: A qualitative and comparative study. Journal of Pain and Symptom Management, 34(2), 126-135. [More Information]
  • Bennett, B., Goldstein, D., Friedlander, M., Hickie, I., Lloyd, A. (2007). The Experience of Cancer-Related Fatigue and Chronic Fatigue Syndrome: A Qualitative and Comparative Study. Journal of Pain and Symptom Management, 34(2), 126-135. [More Information]
  • Butow, P., Eisenbruch, M., Goldstein, D., Duggal-Beri, P., Jefford, M., Schofield, P., Girgis, A., King, M. (2007). Unmet needs in Chinese, Greek and Arabic speaking cancer patients in Australia. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 16(9), S77-S78.
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Tattersall, M., Goldstein, D. (2007). When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer. Journal of Clinical Oncology, 25(18S), 6509.
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Thomson, J., Clarke, S. (2006). Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clinical Colorectal Cancer, 6(2), 146-151. [More Information]
  • Dalton, L., Luxford, K., Boyle, F., Goldstein, D., Underhill, C., Yates, P. (2006). An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy. Journal of Cancer Education, 21(1), 35-39. [More Information]
  • Yip, D., Karapetis, C., Strickland, A., Steer, C., Goldstein, D. (2006). Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, CD002093-CD002093. [More Information]
  • Goldstein, D., Bennett, B., Friedlander, M., Davenport, T., Hickie, I., Lloyd, A. (2006). Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer, 6, 1-8. [More Information]
  • Harrison, M., Goldstein, D. (2006). Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach. Internal Medicine Journal, 36(6), 367-377. [More Information]
  • Goldstein, D., Ackland, S., Bell, D., Olver, I., Davis, I., Rosenthal, M., Toner, G., Pinel, M., Byrne, M. (2006). Phase II study of vinflunine in patients with metastatic renal cell carcinoma. Investigational New Drugs, 24(5), 429-434. [More Information]
  • Grimison, P., Chin, M., Harrison, M., Goldstein, D. (2006). Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer, 4(6), 117. [More Information]
  • Michael, M., Goldstein, D., Clarke, S., Milner, A., Beale, P., Friedlander, M., Mitchell, P. (2006). Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count. Clinical Colorectal Cancer, 6(4), 297-304.
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Shepherd, L., Goldstein, D., Whitford, H., Thewes, B., Brummell, V., Hicks, M. (2006). The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study. Journal of Pain and Symptom Management, 32(5), 453-461. [More Information]
  • Barlow-Stewart, K., Yeo, S., Meiser, B., Goldstein, D., Tucker, K., Eisenbruch, M. (2006). Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24-32. [More Information]
  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology, 23(No 16S (June 1 Supplement)), 3581-3581.
  • Grimison, P., Goldstein, D., Yu, L. (2005). An unusual abdominal mass. Gut (English Edition): an international journal of gastroenterology and hepatology, 54(4), 478. [More Information]
  • Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. British Journal of Cancer, 92(5), 832-837. [More Information]
  • Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
  • Sunghan, K., Goldstein, D., Hasher, L., Zacks, R. (2005). Framing effects in younger and older adults. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 60(4), P215-8. [More Information]
  • Goldstein, D., Tan, B., Rossleigh, M., Haindl, W., Walker, B., Dixon, J. (2005). Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission Tomography with CT for the Assessment of Treatment Response – An AGITG Study. Oncology, 69(4), 326-332. [More Information]
  • Marx, G., Taylor, J., Goldstein, D. (2005). Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience. Internal Medicine Journal, 35(1), 34-38. [More Information]
  • Yeo, S., Meiser, B., Barlow-Stewart, K., Goldstein, D., Tucker, K., Eisenbruch, M. (2005). Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 14(3), 174-186. [More Information]
  • Hughes, B., Yip, D., Chao, M., Gibbs, P., Carroll, S., Goldstein, D., Burmeister, B., Karapetis, C. (2004). Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience. ANZ Journal of Surgery, 74(11), 951-956.
  • Hagerty, R., Butow, P., Ellis, P., Lobb, E., Pendlebury, S., Tattersall, M., Leighl, N., Goldstein, D., Kai Lo, S. (2004). Cancer Patient Preferences For Communication Of Prognosis In The Metastatic Setting. Journal of Clinical Oncology, 22(9), 1721-1730.
  • Hughes, B., Yip, D., Goldstein, D., Waring, P., Beshay, V., Chong, G. (2004). Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report. BMC Cancer, 4(1), 74-80.
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical Features And Predictors Of Survival Of AIDS-Related Non-Hodgkin'S Lymphoma In A Population-Based Case Series In Sydney, Australia. HIV Medicine, 5(5), 377-384.
  • Apte, M., Park, S., Phillips, P., Santucci, N., Goldstein, D., Kumar, R., Ramm, G., Buchler, M., Friess, H., McCarroll, J., et al (2004). Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas, 29(3), 179-187.
  • Brown, R., Butow, P., Sharrock, M., Henman, M., Boyle, F., Goldstein, D., Tattersall, M. (2004). Education And Role Modelling For Clinical Decisions With Female Cancer Patients. Health expectations : an international journal of public participation in health care and health policy, 7(4), 303-316.
  • Bennett, B., Goldstein, D., Lloyd, A., Davenport, T., Hickie, I. (2004). Fatigue and psychological distress - exploring the relationship in women treated for breast cancer. European Journal of Cancer, 40(11), 1689-1695. [More Information]
  • Eisenbruch, M., Yeo, S., Meiser, B., Goldstein, D., Tucker, K., Barlow-Stewart, K. (2004). Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Social Science and Medicine, 59(2), 235-248. [More Information]
  • Heathcote (nee Jong), K., Heathcote (nee Jong), K., Smith, D., Smith, D., Yu, X., Yu, X., O'Connell, D., O'Connell, D., Goldstein, D., Goldstein, D., Armstrong, B., Armstrong, B. (2004). Remoteness Of Residence And Survival From Cancer In New South Wales. Medical Journal of Australia, 180(12), 618-622. [More Information]
  • Goldstein, D., Thewes, B., Butow, P. (2002). Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia. Internal Medicine Journal, 32(7), 289-296.
  • Meiser, B., Eisenbruch, M., Barlow, R., Goldstein, D., Steel, Z., Tucker, K. (2001). Cultural aspects of cancer genetics: setting a research agenda. Journal of Medical Genetics, 38, 425-429.

Conferences

  • Wu, M., Goldstein, D., Alidge, L., McGrane, J., Girgis, A., Eisenbruch, M., King, M., Jefford, M., Schofield, P., Sze, M. (2010). Morbidity, Unmet needs, quality of life and patterns of care in CALD cancer patients in Prince of Wales Hospital. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.

2014

  • Hillman, R., Garland, S., Gunathilake, M., Stevens, M., Kumaradevan, N., Lemech, C., Ward, R., Meagher, A., McHugh, L., Jin, F., et al (2014). Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. International Journal of Cancer, 135(4), 996-1001. [More Information]

2013

  • Grimison, P., Phillips, F., Butow, P., White, K., Yip, D., Sardelic, F., Underhill, C., Tse, R., Simes, R., Turley, K., et al (2013). Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals. Asia-Pacific Journal of Clinical Oncology, 9(3), 226-238. [More Information]
  • Butow, P., Tattersall, M., Clayton, J., Goldstein, D. (2013). Breaking Bad News and Truth Disclosure in Australia. In Antonella Surbone, Matjaz Zwitter, Mirjana Rajer, Richard Stiefel (Eds.), New Challenges in Communication with Cancer Patients, (pp. 377-387). New York: Springer.
  • Park, S., Goldstein, D., Krishnan, A., Lin, C., Friedlander, M., Cassidy, J., Koltzenburg, M., Kiernan, M. (2013). Chemotherapy-induced peripheral neurotoxicity: A critical analysis. CA: A Cancer Journal for Clinicians, 63(6), 419-437. [More Information]
  • Chou, A., Waddell, N., Cowley, M., Gill, A., Chang, D., Patch, A., Nones, K., Wu, J., Pinese, M., Johns, A., Toon, C., et al (2013). Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5(8), 1-11. [More Information]
  • Short (nee Rybovic), M., Goldstein, D., Halkett, G., Reece, W., Borg, M., Zissiadis, Y., Kneebone, A., Spry, N. (2013). Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer. International Journal of Radiation: Oncology - Biology - Physics, 85(1), 157-162. [More Information]
  • Butow, P., Aldridge, L., Bell, M., Sze, M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Duggal, P., McGrane, J., et al (2013). Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study. European Journal of Cancer, 49(8), 1948-1956. [More Information]
  • Bell, M., Butow, P., Goldstein, D. (2013). Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors. Quality of Life Research, 22(10), 2757-2760. [More Information]
  • Shaw, J., Butow, P., Sze, M., Young, J., Goldstein, D. (2013). Reducing disparity in outcomes for immigrants with cancer: a qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention. Supportive Care in Cancer, 21(8), 2297-2301. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information]
  • Butow, P., Bell, M., Aldridge, L., Sze, M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Duggal, P., et al (2013). Unmet needs in immigrant cancer survivors: a cross-sectional population-based study. Supportive Care in Cancer, 21(9), 2509-2520. [More Information]

2012

  • Butow, P., Lobb, E., Jefford, M., Goldstein, D., Eisenbruch, M., Girgis, A., King, M., Sze, M., Aldridge, L., Schofield, P. (2012). A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Supportive Care in Cancer, 20(2), 235-244. [More Information]
  • Goldstein, D., Bennett, B., Webber, K., Boyle, F., De Souza, P., Wilcken, N., Scott, E., Toppler, R., Murie, P., O'Malley, L., Hickie, I., et al (2012). Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study. Journal of Clinical Oncology, 30(15), 1805-1812. [More Information]
  • Bennett, B., Park, S., Lin, C., Friedlander, M., Kiernan, M., Goldstein, D. (2012). Impact of oxaliplatin-induced neuropathy: a patient perspective. Supportive Care in Cancer, 20(11), 2959-2967. [More Information]
  • Cameron, B., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A. (2012). Post-cancer fatigue is not associated with immune activation or altered cytokine production. Annals of Oncology, 23(11), 2890-2895. [More Information]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(5), 496-504. [More Information]
  • Butow, P., Phillips, F., Schweder, J., White, K., Underhill, C., Goldstein, D. (2012). Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Supportive Care in Cancer, 20(1), 1-22. [More Information]
  • Ngan, S., Burmeister, B., Fisher, R., Solomon, M., Goldstein, D., Joseph, D., Ackland, S., Schache, D., McClure, B., McLachlan, S., et al (2012). Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. Journal of Clinical Oncology, 30(31), 3827-3833. [More Information]
  • Goldstein, D., Spry, N., Cummins, M., Brown, C., van Hazel, G., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S., Wratten, C., Hruby, G., Horvath, L., Gebski, V., et al (2012). The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British Journal of Cancer, 106(1), 61-69. [More Information]

2011

  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Dose effects of oxaliplatin on persistent and transient na conductances and the development of neurotoxicity. PLoS One, 6(4), e18469-e18469. [More Information]
  • Butow, P., Sze, M., Duggal-Beri, P., Mikhail (nee Tanious), M., Eisenbruch, M., Jefford, M., Schofield, P., Girgis, A., King, M., Goldstein, D. (2011). From inside the bubble: migrants' perceptions of communication with the cancer Team. Supportive Care in Cancer, 19(2), 281-290. [More Information]
  • Butow, P., Bell, M., Goldstein, D., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Ashgari, R., Hui, R., et al (2011). Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters. Patient Education and Counseling, 84, 398-405. [More Information]
  • Webber, K., Mok, K., Bennett, B., Lloyd, A., Friedlander, M., Juraskova, I., Goldstein, D. (2011). If I Am in the Mood, I Enjoy It: An Exploration of Cancer-Related Fatigue and Sexual Functioning in Women with Breast Cancer. The Oncologist, 16, 1333-1344. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility. The Oncologist, 16(5), 708-716. [More Information]
  • Park, S., Goldstein, D., Lin, C., Krishnan, A., Friedlander, M., Kiernan, M. (2011). Neuroprotection for Oxaliplatin-Induced Neurotoxicity: What Happened to Objective Assessment? Journal of Clinical Oncology, 29(18), e553-e554. [More Information]
  • Luckett, T., Goldstein, D., Butow, P., Gebski, V., Aldridge, L., McGrane, J., Ng, W., King, M. (2011). Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. The Lancet Oncology, 12(13), 1240-1248. [More Information]
  • Tebbutt, N., Murphy, F., Zannino, D., Wilson, C., Cummins, M., Abdi, E., Strickland, A., Lowenthal, R., Marx, G., Karapetis, C., Shannon, J., Simes, R., et al (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology, 22(8), 1834-1838. [More Information]
  • Sze, M., Butow, P., Goldstein, D., Jefford, M., Girgis, A., Eisenbruch, M., Bell, M., Vaccaro, L., Dong, S., Liauw, W., et al (2011). Shared Decision Making in Immigrants With Cancer. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 20(Suppl 2), 12-13.
  • Clarke, S., Yip, S., Brown, C., van Hazel, G., Ransom, D., Goldstein, D., Jeffrey, G., Tebbutt, N., Buck, M., Lowenthal, R., Boland, A., Gebski, V., Simes, R., et al (2011). Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis. European Journal of Cancer, 47(12), 1826-1836. [More Information]
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Goldstein, D., Horvath, L., Tattersall, M., et al (2011). Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy. Journal of Clinical Oncology, 29(15), 2077-2084. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2011). Utilising natural activity to dissect the Pathophysiology of acute oxaliplatin-induced neuropathy. Experimental Neurology, 227(1), 120-127. [More Information]

2010

  • Butow, P., Lobb, E., Jefford, M., Goldstein, D., Eisenbruch, M., Girgis, A., King, M., Sze, M., Aldridge, L., Schofield, P. (2010). A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Supportive Care in Cancer, , 1-10. [More Information]
  • Lovell, M., Forder, P., Stockler, M., Butow, P., Briganti, E., Chye, R., Goldstein, D., Boyle, F. (2010). A Randomized Controlled Trial of a Standardized Educational Intervention for Patients with Cancer Pain. Journal of Pain and Symptom Management, 40(1), 49-59. [More Information]
  • Sjoquist, K., Goldstein, D., Bester, L. (2010). A serious complication of selected internal radiation therapy: case report and literature review. The Oncologist, 15(8), 830-835. [More Information]
  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Neoptolemos, J., Stocken, D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M., Gallinger, S., Mariette, C., et al (2010). Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: A Randomized Controlled Trial. JAMA: The Journal of the American Medical Association, 304(10), 1073-1081. [More Information]
  • Goldstein, D., Gainford, M., Brown, C., Tebbutt, N., Ackland, S., van Hazel, G., Jefford, M., Abdi, E., Selva-Nayagam, S., Gebski, V., Miller, D., et al (2010). Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemotherapy and Pharmacology, , 1-7. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Wu, M., Goldstein, D., Alidge, L., McGrane, J., Girgis, A., Eisenbruch, M., King, M., Jefford, M., Schofield, P., Sze, M. (2010). Morbidity, Unmet needs, quality of life and patterns of care in CALD cancer patients in Prince of Wales Hospital. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Koczwara, B., Francis, K., Marine, F., Goldstein, D., Underhill, C., Olver, I. (2010). Reaching further with online education? The development of an effective online program in palliative oncology. Journal of Cancer Education, 25(3), 317-323. [More Information]

2009

  • Park, S., Goldstein, D., Lin, C., Krishnan, A., Friedlander, M., Kiernan, M. (2009). Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. Journal of Clinical Oncology, 27(8), 1243-1249. [More Information]
  • Girgis, A., Hansen, V., Goldstein, D. (2009). Are Australian oncology health professionals burning out? A view from the trenchs. European Journal of Cancer, 45, 393-399. [More Information]
  • Underhill, C., Bartel, R., Goldstein, D., Snodgrass, H., Begbie, S., Yates, P., White, K., Jong, K., Grogan, P. (2009). Mapping oncology services in regional and rural Australia. Australian Journal of Rural Health, 17, 321-329. [More Information]
  • Chua, W., Goldstein, D., Lee, C., Dhillon, H., Michael, M., Mitchell, P., Clark, S., Iacopetta, B. (2009). Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. British Journal of Cancer, 101(6), 998-1004. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2009). Oxaliplatin-Induced Lhermitte's Phenomenon as a Manifestation of Severe Generalized Neurotoxicity. Neuro-Oncology, 77(6), 342-348. [More Information]
  • Park, S., Lin, C., Krishnan, A., Goldstein, D., Friedlander, M., Kiernan, M. (2009). Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain: a journal of neurology, 132(10), 2712-2723. [More Information]
  • Van Hazel, G., Pavlakis, N., Goldstein, D., Olver, I., Tapner, M., Price, D., Bower, G., Briggs, G., Rossleigh, M., Taylor, D., George, J. (2009). Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy. Journal of Clinical Oncology, 27(25), 4089-4095. [More Information]
  • Lee, C., Hadley, A., DeSilva, K., Smith, G., Goldstein, D. (2009). When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis. World Journal of Surgical Oncology, 7(8), 1-4. [More Information]

2008

  • Butow, P., Girgis, A., Goldstein, D., Eisenbruch, M., Schofield, P., King, M., Jefford, M., Duggal-Beri, P., Sze, M., Mikhail (nee Tanious), M., et al (2008). Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 17, S280-S280.
  • Shepherd, L., Goldstein, D., Olver, I., Parle, M. (2008). Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer? Australian Health Review, 32(3), 423-438. [More Information]
  • Vonlaufen, A., Joshi, S., Qu, C., Phillips, P., Xu, Z., Parker, N., Toi, C., Pirola, R., Wilson, J., Goldstein, D., et al (2008). Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Research, 68(7), 2085-2093. [More Information]

2007

  • Xavier, K., Shepherd, L., Goldstein, D. (2007). Clinical supervision and education via videoconference: a feasibility project. Journal of Telemedicine and Telecare, 13(4), 206-209. [More Information]
  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]
  • Moore, M., Goldstein, D., Hamm, J., Figer, A., Hecht, J., Gallinger, S., Au, H., Murawa, P., Walde, D., Wolff, R., et al (2007). Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 25(15), 1960-1966. [More Information]
  • Clarke, S., Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S. (2007). Modification of Leucovorin Dose Within a Simplified FOLFOX Regimen Improves Tolerability Without Compromising Efficacy. Clinical Colorectal Cancer, 6(8), 578-582. [More Information]
  • Bennett, B., Goldstein, D., Friedlander, M., Hickie, I., Lloyd, A. (2007). The experience of cancer related fatigue and chronic fatigue syndrome: A qualitative and comparative study. Journal of Pain and Symptom Management, 34(2), 126-135. [More Information]
  • Bennett, B., Goldstein, D., Friedlander, M., Hickie, I., Lloyd, A. (2007). The Experience of Cancer-Related Fatigue and Chronic Fatigue Syndrome: A Qualitative and Comparative Study. Journal of Pain and Symptom Management, 34(2), 126-135. [More Information]
  • Butow, P., Eisenbruch, M., Goldstein, D., Duggal-Beri, P., Jefford, M., Schofield, P., Girgis, A., King, M. (2007). Unmet needs in Chinese, Greek and Arabic speaking cancer patients in Australia. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 16(9), S77-S78.
  • Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Tattersall, M., Goldstein, D. (2007). When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer. Journal of Clinical Oncology, 25(18S), 6509.

2006

  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Thomson, J., Clarke, S. (2006). Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clinical Colorectal Cancer, 6(2), 146-151. [More Information]
  • Dalton, L., Luxford, K., Boyle, F., Goldstein, D., Underhill, C., Yates, P. (2006). An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy. Journal of Cancer Education, 21(1), 35-39. [More Information]
  • Yip, D., Karapetis, C., Strickland, A., Steer, C., Goldstein, D. (2006). Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, CD002093-CD002093. [More Information]
  • Goldstein, D., Bennett, B., Friedlander, M., Davenport, T., Hickie, I., Lloyd, A. (2006). Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer, 6, 1-8. [More Information]
  • Harrison, M., Goldstein, D. (2006). Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach. Internal Medicine Journal, 36(6), 367-377. [More Information]
  • Goldstein, D., Ackland, S., Bell, D., Olver, I., Davis, I., Rosenthal, M., Toner, G., Pinel, M., Byrne, M. (2006). Phase II study of vinflunine in patients with metastatic renal cell carcinoma. Investigational New Drugs, 24(5), 429-434. [More Information]
  • Grimison, P., Chin, M., Harrison, M., Goldstein, D. (2006). Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer, 4(6), 117. [More Information]
  • Michael, M., Goldstein, D., Clarke, S., Milner, A., Beale, P., Friedlander, M., Mitchell, P. (2006). Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count. Clinical Colorectal Cancer, 6(4), 297-304.
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Shepherd, L., Goldstein, D., Whitford, H., Thewes, B., Brummell, V., Hicks, M. (2006). The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study. Journal of Pain and Symptom Management, 32(5), 453-461. [More Information]
  • Barlow-Stewart, K., Yeo, S., Meiser, B., Goldstein, D., Tucker, K., Eisenbruch, M. (2006). Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24-32. [More Information]

2005

  • Mitchell, P., Goldstein, D., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology, 23(No 16S (June 1 Supplement)), 3581-3581.
  • Grimison, P., Goldstein, D., Yu, L. (2005). An unusual abdominal mass. Gut (English Edition): an international journal of gastroenterology and hepatology, 54(4), 478. [More Information]
  • Goldstein, D., Mitchell, P., Michael, M., Beale, P., Friedlander, M., Zalcberg, J., White, S., Clarke, S. (2005). Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. British Journal of Cancer, 92(5), 832-837. [More Information]
  • Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
  • Sunghan, K., Goldstein, D., Hasher, L., Zacks, R. (2005). Framing effects in younger and older adults. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 60(4), P215-8. [More Information]
  • Goldstein, D., Tan, B., Rossleigh, M., Haindl, W., Walker, B., Dixon, J. (2005). Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission Tomography with CT for the Assessment of Treatment Response – An AGITG Study. Oncology, 69(4), 326-332. [More Information]
  • Marx, G., Taylor, J., Goldstein, D. (2005). Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience. Internal Medicine Journal, 35(1), 34-38. [More Information]
  • Yeo, S., Meiser, B., Barlow-Stewart, K., Goldstein, D., Tucker, K., Eisenbruch, M. (2005). Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 14(3), 174-186. [More Information]

2004

  • Hughes, B., Yip, D., Chao, M., Gibbs, P., Carroll, S., Goldstein, D., Burmeister, B., Karapetis, C. (2004). Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience. ANZ Journal of Surgery, 74(11), 951-956.
  • Hagerty, R., Butow, P., Ellis, P., Lobb, E., Pendlebury, S., Tattersall, M., Leighl, N., Goldstein, D., Kai Lo, S. (2004). Cancer Patient Preferences For Communication Of Prognosis In The Metastatic Setting. Journal of Clinical Oncology, 22(9), 1721-1730.
  • Hughes, B., Yip, D., Goldstein, D., Waring, P., Beshay, V., Chong, G. (2004). Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report. BMC Cancer, 4(1), 74-80.
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical Features And Predictors Of Survival Of AIDS-Related Non-Hodgkin'S Lymphoma In A Population-Based Case Series In Sydney, Australia. HIV Medicine, 5(5), 377-384.
  • Apte, M., Park, S., Phillips, P., Santucci, N., Goldstein, D., Kumar, R., Ramm, G., Buchler, M., Friess, H., McCarroll, J., et al (2004). Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas, 29(3), 179-187.
  • Brown, R., Butow, P., Sharrock, M., Henman, M., Boyle, F., Goldstein, D., Tattersall, M. (2004). Education And Role Modelling For Clinical Decisions With Female Cancer Patients. Health expectations : an international journal of public participation in health care and health policy, 7(4), 303-316.
  • Bennett, B., Goldstein, D., Lloyd, A., Davenport, T., Hickie, I. (2004). Fatigue and psychological distress - exploring the relationship in women treated for breast cancer. European Journal of Cancer, 40(11), 1689-1695. [More Information]
  • Eisenbruch, M., Yeo, S., Meiser, B., Goldstein, D., Tucker, K., Barlow-Stewart, K. (2004). Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Social Science and Medicine, 59(2), 235-248. [More Information]
  • Heathcote (nee Jong), K., Heathcote (nee Jong), K., Smith, D., Smith, D., Yu, X., Yu, X., O'Connell, D., O'Connell, D., Goldstein, D., Goldstein, D., Armstrong, B., Armstrong, B. (2004). Remoteness Of Residence And Survival From Cancer In New South Wales. Medical Journal of Australia, 180(12), 618-622. [More Information]

2002

  • Goldstein, D., Thewes, B., Butow, P. (2002). Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia. Internal Medicine Journal, 32(7), 289-296.

2001

  • Meiser, B., Eisenbruch, M., Barlow, R., Goldstein, D., Steel, Z., Tucker, K. (2001). Cultural aspects of cancer genetics: setting a research agenda. Journal of Medical Genetics, 38, 425-429.

To update your profile click here. For support on your academic profile contact .